Metabonomics comparison of coronary heart disease with and without turbid phlegm syndrome

References

• Roth, G. A.; Johnson, C.; Abajobir, A.; Abd-Allah, F.; Abera, S. F.; Abyu, G.; Ahmed, M.; Aksut, B.; Alam, T.; Alam, K.; et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes,1990 to 2015. J. Am. Coll. Cardiol. 2017, 70, 1–25. DOI: 10.1016/j.jacc.2017.04.052.
   PubMed Web of Science ®Google Scholar
• Chinese Preventive Medicine Association; Branch of Heart Disease Prevention and Control, Chinese Preventive Medicine Association; Chinese Diabetes Society; Branch of Stroke Prevention and Control, Chinese Preventive Medicine Association; Chinese Health Management Society; Branch of Non-communicable Chronic Disease Prevention and Control, Chinese Preventive Medicine Association; Branch of Hypertension, China International Exchange and Promotion Association for Medical and Healthcare; Community Health Association of China. Chinese Guideline on Healthy Lifestyle to Prevent Cardiometabolic Diseases. Chinese J. Health Manage. 2020, 14, 113–134.
   Google Scholar
• Mao, J.; Niu, Z.; Zhang, B. Literature Analysis of Studies on the TCM Syndromes of Coronary Heart Disease in the Recent 40 Years. J. Tradit. Chin. Med. 2011, 52, 958–961.
   Google Scholar
• Xing, Y.; Wang, J.; Zhong, J. Clustering Analysis and Corresponding Correlation Method Were Used to Study the Combination of Symptoms and Symptoms of 1069 Cases of Coronary Heart Disease Angina Pectoris. J. Tradit. Chin. Med. 2007, 22, 747–750.
   Google Scholar
• Nicholson, J. K.; Connelly, J.; Lindon, J. C.; Holmes, E. Metabonomics: A Platform for Studying Drug Toxicity and Gene Function. Nat. Rev. Drug Discov. 2002, 1, 153–161. DOI: 10.1038/nrd728.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology, Chinese Medical Association; Editorial Board, Chinese Journal of Cardiology. Guideline for Diagnosis and Treatment of Patients with Chronic Stable Angina (No Abstract). Zhonghua Xin Xue Guan Bing Za Zhi 2007, 35, 195–206.
   PubMedGoogle Scholar
• Zheng, X. Y., Eds. Guiding Principles for Clinical Research of New Chinese Medicine; China Pharmaceutical Science and Technology Press: Beijing; 2002.
   Google Scholar
• Huang, X.; Wang, F.; Zhao, X. Analysis of the Risk Factors of Coronary Heart Disease by Logistic Regression. Shanghai Med. Pharma. J. 2017.
   Google Scholar
• Dudzik, D.; Barbas-Bernardos, C.; García, A.; Barbas, C. Quality Assurance Procedures for Mass Spectrometry Untargeted Metabolomic. A Review. J. Pharm. Biomed. Anal. 2018, 147, 149–173. DOI: 10.1016/j.jpba.2017.07.044.
   PubMed Web of Science ®Google Scholar
• Thomas, E.; An-Long, X.; David, Y. W. L. Combining the Wisdoms of Traditional Medicine with Cutting-Edge Science and Technology at the Forefront of Medical Sciences. Phytomedicine 2019, 64, 153078.
   PubMed Web of Science ®Google Scholar
• Du, H.; Wang, L.; Liu, B.; Wang, J.; Su, H.; Zhang, T.; Huang, Z. Analysis of the Metabolic Characteristics of Serum Samples in Patients with Multiple Myeloma. Front. Pharmacol. 2018, 9, 884. DOI: 10.3389/fphar.2018.00884.
   PubMed Web of Science ®Google Scholar
• Huss, J. M.; Kelly, D. P. Nuclear Receptor Signaling and Cardiac Energetics. Circ. Res. 2004, 95, 568–578. DOI: 10.1161/01.RES.0000141774.29937.e3.
   PubMed Web of Science ®Google Scholar
• Sarkar, S.; Khan, M. F.; Kaphalia, B. S.; Ansari, G. A. Methyl Palmitate Inhibits Lipopolysaccharide-Stimulated Phagocytic Activity of Rat Peritoneal Macrophages. J. Biochem. Mol. Toxicol. 2006, 20, 302–308. DOI: 10.1002/jbt.20150.
   PubMed Web of Science ®Google Scholar
• Feng, Q.; Liu, Z.; Zhong, S.; Li, R.; Xia, H.; Jie, Z.; Wen, B.; Chen, X.; Yan, W.; Fan, Y.; et al. Integrated Metabolomics and Metagenomics Analysis of Plasma and Urine Identified Microbial Metabolites Associated with Coronary Heart Disease. Sci. Rep. 2016, 6, 22525. DOI: 10.1038/srep22525.
   PubMed Web of Science ®Google Scholar
• Schaeffer, P. J.; Wende, A. R.; Magee, C. J.; Neilson, J. R.; Leone, T. C.; Chen, F.; Kelly, D. P. Calcineurin and Calcium/Calmodulin-Dependent Protein Kinase Activate Distinct Metabolic Gene Regulatory Programs in Cardiac Muscle. J. Biol. Chem. 2004, 279, 39593–39603. DOI: 10.1074/jbc.M403649200.
   PubMed Web of Science ®Google Scholar
• Boyanovsky, B. B.; Webb, N. R. Biology of Secretory Phospholipase A2. Cardiovasc. Drugs Ther. 2009, 23, 61–72. DOI: 10.1007/s10557-008-6134-7.
   PubMed Web of Science ®Google Scholar
• Cai, P.; Kaphalia, B. S.; Ansari, G. A. S. Methyl Palmitate: inhibitor of Phagocytosis in Primary Rat Kupffer Cells. Toxicology 2005, 210, 197–204. DOI: 10.1016/j.tox.2005.02.001.
   PubMed Web of Science ®Google Scholar
• El-Demerdash, E. Anti-Inflammatory and Anti-Fibrotic Effects of Methyl Palmitate. Toxicol. Appl. Pharmacol. 2011, 254, 238–244. DOI: 10.1016/j.taap.2011.04.016.
   PubMed Web of Science ®Google Scholar
• Mantawy, E. M.; Tadros, M. G.; Awad, A. S.; Hassan, D. A.; El-Demerdash, E. Insights Antifibrotic Mechanism of Methyl Palmitate: Impact on Nuclear Factor Kappa B and Proinflammatory Cytokines. Toxicol. Appl. Pharmacol. 2012, 258, 134–144. DOI: 10.1016/j.taap.2011.10.016.
   PubMed Web of Science ®Google Scholar
• Saeed, N. M.; El-Demerdash, E.; Abdel-Rahman, H. M.; Algandaby, M. M.; Al-Abbasi, F. A.; Abdel-Naim, A. B. Anti-Inflammatory Activity of Methyl Palmitate and Ethyl Palmitate in Different Experimental Rat Models. Toxicol. Appl. Pharmacol. 2012, 264, 84–93. DOI: 10.1016/j.taap.2012.07.020.
   PubMed Web of Science ®Google Scholar
• Sharawy, M. H.; El-Agamy, D. S.; Shalaby, A. A.; Ammar el, S. M. Protective Effects of Methyl Palmitate against Silica-Induced Pulmonary Fibrosis in Rats. Int. Immunopharmacol. 2013, 16, 191–198. DOI: 10.1016/j.intimp.2013.04.007.
   PubMed Web of Science ®Google Scholar
• Akasaka, H.; Ruan, K. H. Identification of the Two–Phase Mechanism of Endogenous Omega-6 Fatty Acid, Arachidonic Acid, Regulating Vascular Inflammation by Targeting Cyclooxygenase-2 and Microsomal Prostaglandin e2 Syn-Thase-1. J. Am. Coll. Cardiol. 2016, 67, 2318. DOI: 10.1016/S0735-1097(16)32319-1.
   PubMed Web of Science ®Google Scholar
• Würtz, P.; Havulinna, A. S.; Soininen, P.; Tynkkynen, T.; Prieto-Merino, D.; Tillin, T.; Ghorbani, A.; Artati, A.; Wang, Q.; Tiainen, M.; et al. Metabolite Profiling and Cardiovascular Event Risk: A Prospective Study of Three Population-Based Cohorts. Circulation 2015, 131, 774–785. DOI: 10.1161/CIRCULATIONAHA.114.013116.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Zhang, D.; He, Y.; Chen, C.; Song, C.; Zhao, Y.; Bai, Y.; Wang, Y.; Pu, J.; Chen, J.; et al. Investigation of Novel Metabolites Potentially Involved in the Pathogenesis of Coronary Heart Disease Using a UHPLC-QTOF/MS-Based Metabolomics Approach. Sci. Rep. 2017, 7, 15357. DOI: 10.1038/s41598-017-15737-3.
   PubMed Web of Science ®Google Scholar